ArticleBioinformatics advances2026
GPTBioInsightor-leveraging large language models for transparent scRAN-seq cell type annotations.
Article in Bioinformatics advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Motivation: Large language models (LLMs) are rapidly becoming indispensable across the life‑sciences spectrum, from literature mining through clinical decision support to experimental design. Yet, in single‑cell RNA‑sequencing (scRNA‑seq) analysis, most LLM‑enabled tools remain opaque: they output a single label per cluster without disclosing the chain‑of‑ thought that led to that decision. This opaqueness undermines reproducibility, complicates peer‑review, and ultimately slows the adoption of otherwise powerful methods. Results: We developed GPTBioInsightor, an LLM‑powered assistant that not only annotates cell types, cell states, and pathway activities but also narrates how it arrived at each conclusion, step-by-step. Across benchmark datasets-including peripheral blood mononuclear cells (PBMC3K) and pancreatic ductal adenocarcinoma-GPTBioInsightor achieved at least parity with expert manual curation while delivering transparent reasoning, confidence scores, and literature‑based evidence. By closing the "interpretability gap," GPTBioInsightor equips wet‑lab biologists, computational scientists, and reviewers with an audit‑ready trail, thereby accelerating discovery and fostering trust in AI‑assisted bioinformatics. Availability and implementation: GPTBioInsightor is freely available on GitHub under a BSD-3-Clause license (https://github.com/huang-sh/GPTBioInsightor).
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.